We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORI
601
DELISTED
Corium International, Inc.
CORI
$826K 0.01%
86,000
+68,000
+378% +$725K
CGNX icon
602
Cognex
CGNX
$10.3B
$821K 0.01%
+13,430
New +$855K
CHL
603
DELISTED
China Mobile Limited
CHL
$815K 0.01%
16,080
-1,100
-6% -$55.4K
HRL icon
604
Hormel Foods
HRL
$13.9B
$811K 0.01%
22,289
+3,255
+17% +$109K
ALV icon
605
Autoliv
ALV
$8.6B
$803K 0.01%
8,774
MELI icon
606
Mercado Libre
MELI
$91.3B
$786K 0.01%
2,498
-15
-0.6% -$4.06K
NOV icon
607
NOV
NOV
$7.45B
$784K 0.01%
21,758
-27,264
-56% -$922K
XEC
608
DELISTED
CIMAREX ENERGY CO
XEC
$776K 0.01%
6,363
-5,003
-44% -$583K
CAJ
609
DELISTED
Canon, Inc.
CAJ
$767K 0.01%
20,400
CP icon
610
Canadian Pacific Kansas City
CP
$82B
$760K 0.01%
20,740
+1,660
+9% +$57.8K
NTES icon
611
NetEase
NTES
$76.5B
$752K 0.01%
10,900
CPT icon
612
Camden Property Trust
CPT
$11.3B
$738K 0.01%
8,017
-1,093
-12% -$101K
AZN icon
613
AstraZeneca
AZN
$263B
$736K 0.01%
10,600
-6,838
-39% -$461K
DISH
614
DELISTED
DISH Network Corp.
DISH
$733K 0.01%
15,342
+353
+2% +$17.6K
XL
615
DELISTED
XL Group Ltd.
XL
$724K 0.01%
20,583
-107,407
-84% -$4.17M
CF icon
616
CF Industries
CF
$19.2B
$723K 0.01%
16,998
BMS
617
DELISTED
Bemis
BMS
$717K 0.01%
15,000
-17,680
-54% -$817K
SNA icon
618
Snap-on
SNA
$20.9B
$714K 0.01%
4,095
+478
+13% +$77.3K
HE icon
619
Hawaiian Electric Industries
HE
$2.33B
$707K 0.01%
19,544
MOS icon
620
The Mosaic Company
MOS
$7.09B
$706K 0.01%
27,504
-103,346
-79% -$2.37M
OFIX icon
621
Orthofix Medical
OFIX
$455M
$690K 0.01%
12,612
+4,755
+61% +$247K
AKAM icon
622
Akamai
AKAM
$16.8B
$687K 0.01%
10,561
-69,291
-87% -$3.84M
TRIL
623
DELISTED
Trillium Therapeutics Inc.
TRIL
$683K 0.01%
94,000
-16,000
-15% -$133K
MAT icon
624
Mattel
MAT
$4.17B
$679K 0.01%
44,169
-440,530
-91% -$6.98M
VER
625
DELISTED
VEREIT, Inc.
VER
$669K 0.01%
17,186

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.